Plain-Language FAQ

Is ME/CFS a Real Illness?

Yes. Unambiguously and without qualification, yes. Myalgic encephalomyelitis/chronic fatigue syndrome is a serious, complex, chronic illness recognised by the World Health Organization, the National Institutes of Health in the United States, and medical bodies across the world. It is not invented, exaggerated, or a personality trait. Research conducted at institutions including Griffith University's National Centre for Neuroimmunology and Emerging Diseases (NCNED) in Queensland, Australia has identified measurable biological abnormalities in patients — including dysfunctions in calcium ion channels and immune-system signalling — that have no parallel in healthy controls. These are not subtle statistical blips; they are real, reproducible, physical differences in the body.

The reason ME/CFS sometimes gets called "controversial" has nothing to do with whether patients are genuinely ill. It reflects a long and unfortunate history of under-funding, under-research, and, in some cases, active institutional resistance to taking patients seriously. That history is changing, slowly, but the illness itself was never in doubt to the people living with it.

Is It "All in the Mind"?

No — and it is worth understanding exactly why this framing is wrong. For decades, some clinicians and researchers argued that ME/CFS was primarily a psychological condition, maintained by unhelpful beliefs about illness and deconditioned bodies. That view shaped treatment guidelines that favoured cognitive behavioural therapy and graded exercise therapy. Patient communities, advocacy organisations, and researchers pushed back, and the evidence has increasingly vindicated them. Large-scale studies and systematic reviews have consistently failed to show that graded exercise therapy is safe or effective for ME/CFS, and updated guidance from major health bodies in the UK and elsewhere now reflects that.

The biological findings are accumulating. Abnormalities in neuroimmunological function, disrupted energy metabolism in cells, autonomic nervous system dysfunction, and immune activation have all been documented in peer-reviewed literature, searchable through databases like PubMed and indexed through resources like Scopus and Web of Science. ME/CFS is, to borrow the most precise available term, pathological — caused by measurable physical processes. That it also causes profound suffering, and that some patients benefit from psychological support as a coping tool, does not make it psychosomatic. Mental health support is valuable for many serious physical illnesses; that does not make those illnesses imaginary.

What Causes It? Can It Be Caught?

The honest answer is that the precise cause has not been identified, and researchers are cautious about overclaiming. What is well-established is that many cases appear to follow an acute infection — a viral or bacterial illness that the body never fully resolves. Viruses that have been investigated as possible triggers include the Epstein-Barr virus and human herpesvirus 6 (HHV-6), among others. The sharp rise in post-COVID illness since 2020, and the overlap between long COVID and ME/CFS in symptoms and biology, has dramatically accelerated interest and funding in this area.

ME/CFS is not contagious in the way a cold or flu is. You cannot catch it from being near someone who has it, sharing their space, or caring for them. It is not a communicable disease. What may be transmissible is the initial infectious trigger — a flu or a coronavirus — but the vast majority of people who catch such viruses do not develop ME/CFS. Why some people do and others don't remains a central unanswered question in research. Genetic factors, immune system variation, and the timing and severity of the triggering infection are all being studied.

How Is ME/CFS Different from Ordinary Tiredness or Burnout?

This question matters enormously, because it gets at the heart of why patients are so often dismissed. Ordinary tiredness — the kind that comes from a demanding week, poor sleep, or emotional stress — resolves with rest. Burnout, while genuinely serious, typically improves with recovery time and reduced pressure. ME/CFS does neither of these things.

The defining feature that sets ME/CFS apart from every other fatigue-related condition is post-exertional malaise, or PEM. This is not just feeling tired after effort; it is a systematic, sometimes severe worsening of all symptoms — cognitive, physical, and neurological — following even modest physical or mental exertion. A short walk, a phone call, a shower: any of these can trigger a PEM crash that lasts hours, days, or weeks. Many patients describe it as feeling like their body has been poisoned. People with burnout do not experience this. People with depression do not experience this. It is a biological signal, and it is the reason rest and pacing — staying within one's energy envelope — are not optional lifestyle choices for ME/CFS patients; they are medical necessities.

The fatigue in ME/CFS is also unrefreshing. No amount of sleep reliably restores energy. Patients frequently describe waking from eight or ten hours of sleep feeling as exhausted as when they went to bed — sometimes more so. This, combined with cognitive impairment (the "brain fog" that can make reading, speaking, or simple arithmetic feel impossible), orthostatic intolerance, and widespread pain, creates an illness burden that standardised tools like the SF-36 Physical Function subscale consistently rate as comparable to or worse than many cancers and heart conditions.

Is There a Test? Can You Recover?

There is currently no single diagnostic biomarker test for ME/CFS — no blood panel, no scan, no biopsy that definitively confirms the diagnosis. This is one of the most frustrating realities for patients and clinicians alike, and it is why diagnosis often takes years and requires ruling out other conditions first. Researchers, including those at NCNED and groups connected with the European Network on ME/CFS (EUROMENE), are working to validate potential biomarkers, and there is genuine optimism that reliable diagnostic tools will eventually emerge.

Diagnosis today is made clinically, using recognised criteria that require: at least six months of debilitating fatigue that is not explained by other conditions; post-exertional malaise; unrefreshing sleep; and either cognitive impairment or orthostatic intolerance. Meeting these criteria carefully, with a knowledgeable clinician, is possible.

As for recovery: the picture is mixed and honest. Some people — particularly those diagnosed early, who receive appropriate management advice from the outset and avoid the push-and-crash cycle — do see meaningful improvement over time, and a smaller number recover significantly. Many others have a relapsing-remitting course, with periods of relative stability punctuated by relapses. A substantial proportion remain seriously ill for years or decades. There is no approved cure. Treatments like rintatolimod (Ampligen), developed by Hemispherx Biopharma and reviewed by the FDA, have been studied as investigational options, but no single treatment has been shown to reliably reverse the illness. Management focuses on symptom reduction, pacing, and protecting patients from further decline.

None of this should be read as hopelessness. Research investment has grown substantially. Patient advocates, journalists like Mindy Kitei of CFS Central, researchers like Don Staines at Griffith University, and communities built around platforms like Health Rising and Phoenix Rising have collectively ensured that ME/CFS can no longer be quietly ignored. Understanding is accumulating. For people living with the illness now, support groups such as the ME/CFS/FM Support Association Queensland and equivalent organisations worldwide offer knowledge, solidarity, and practical guidance that no FAQ can fully replace.